Obesity Clinical Trial
Official title:
The Impact of Higher Dairy and Dietary Protein on the "Quality" of Hypoenergetic diet-and Exercise-induced Weight Loss in Pre-menopausal, Overweight and Obese Young Women
| Verified date | July 2011 |
| Source | McMaster University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Canada: Ethics Review CommitteeCanada: Health Canada |
| Study type | Interventional |
Diets all share the same principle: eat less energy than you need. This results in weight
loss. However, the weight loss is usually a combination of a loss of body fat and muscle
mass. Additionally, one's bones may begin to weaken, albeit very slowly, while on a diet,
which could have serious long-term consequences. Thus, the investigators believe that the
goal of any weight loss strategy should be to lose body fat and spare muscle. The
investigators reasoning is two-fold. 1) Fat is not only stored under the skin, but also in
and around the internal organs. When this occurs, the organ itself may not function
properly. Losing fat mass is a very good thing from a health standpoint, since fat is not
just a storage site for extra energy. Scientists have now shown that 'extra' body fat itself
can actually secrete substances and when these substances get into your blood, they cause
many problems and may even contribute to the development of diabetes. 2) Sparing muscle as
an individual loses weight is very important. Muscle is a very 'metabolically active' tissue
and is, by analogy, like the body's furnace. Muscle burns fuel from the food individuals eat
and also from stored fuels, like fat. Hence, it's easy to see why you don't want to lose
muscle because you'd be losing one of your body's best fat burners. More importantly, muscle
is also a big storage site and furnace for blood sugar. In people with diabetes (elevated
blood sugar), a big part of the problem is with their muscles - they simply do not take up
and store or burn enough sugar. For these reasons, your goal should be to lose fat and
preserve muscle while dieting.
There are many different diets to choose from (e.g. high protein, low carbohydrate, high
fat, high fiber, etc.). A diet that has been shown to be quite successful, however, is one
that is higher in protein (but not excessive). Thus, in this study, the investigators are
proposing to test whether a higher protein (with dairy) and calcium diet promotes body fat
loss and muscle mass retention. The investigators believe that a diet higher in protein
(with an emphasis on dairy), but still within accepted healthy ranges, with higher dietary
calcium may result in greater loss of body fat and retention of muscle than a diet with a
conventional amount of protein and adequate calcium or a conventional amount of protein with
little calcium (i.e. low dairy). Based on previous research, the investigators think that
people with low calcium intakes to begin with would stand to benefit the most. There is also
a good reason to think that the high protein/high calcium diet may result in greater
reductions in blood cholesterol and blood sugar, both of which would reduce a person's risk
for heart disease and diabetes.
The investigators will test this diet in premenopausal women who are overweight or obese.
The investigators believe that this group is a good one to target for several reasons.
First, women of this age who are overweight or obese are, if they continue to carry this
excess weight, are at serious risk for developing chronic diseases such as heart disease,
diabetes, and possibly cancer at an early age. Second, these women will often begin to
gradually consume less dairy because many perceive dairy foods as fattening. Thus, if the
investigators proposals are correct the investigators will hopefully be able to equip health
professionals with a tried and tested, palatable, dietary strategy in a population segment
who, because of their age, would benefit greatly were their disease risk to be reduced.
| Status | Completed |
| Enrollment | 90 |
| Est. completion date | January 2011 |
| Est. primary completion date | May 2010 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | 19 Years to 45 Years |
| Eligibility |
Inclusion Criteria: - Healthy pre-menopausal females - Body Mass Index (BMI) between 27-40 kg/m2 - Low dairy consumption (~<500 mg/d Ca2+) - Sedentary lifestyle (i.e., exercise less than once/week) - Regular menstrual cycle Exclusion Criteria: - Allergy to dairy protein - Lactose intolerance - Vegan diet - Pregnant - Taking vitamin or mineral supplements - Have a gastrointestinal disease or condition - Recent orthopedic injury - Diagnosed with heart, kidney, liver or pancreatic disease - Smoker - Alcohol consumption of more than 2 drinks/day |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| Canada | McMaster University | Hamilton | Ontario |
| Lead Sponsor | Collaborator |
|---|---|
| McMaster University | Dairy Farmers of Canada, Dairy Management Inc., Hamilton Health Sciences Corporation |
Canada,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Fat mass, lean mass, bone mass (BMD, BMC), total mass (measured via DXA scan) | Measured at weeks 0, 8 and 16 | No | |
| Secondary | Blood sample analyses (lipids) | Measured at weeks 0, 4, 8, 12 and 16 | No | |
| Secondary | Muscle and adipose tissue biopsies | Measured at weeks 0 and 16 | No | |
| Secondary | Food record macronutrient and micronutrient analyses (7-day at beginning and end, and 3-day throughout intervention) | Biweekly from weeks 0-16 | No | |
| Secondary | Resting Energy Expenditure (metabolic cart determination). | Measured at weeks 0 and 16 | No | |
| Secondary | Fitness and strength measures (modified Astrand Test and 1 RM test) | Measured at weeks 0 and 16 | No | |
| Secondary | Blood sample analyses (Vitamin D [25OHD], PTH, A1c, glucose, insulin) | Measured at weeks 0 and 16 | No | |
| Secondary | Magnetic Resonance Imaging (MRI) *strictly on a voluntary basis | Measured at weeks 0 and 16 | No | |
| Secondary | Spot Urine Collection | Measured at weeks 0 and 16 | No | |
| Secondary | Body Image (Assessed with a validated questionnaire) | Measured at weeks 0, 8 and 16 | No | |
| Secondary | Cardiovascular Measures (Assessment of blood pressure, heart rate, blood vessel stiffness and arterial elasticity) | Measured at weeks 0 and 16 | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |